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Superficial Shoulder Muscle Synergy Analysis in
Facioscapulohumeral Dystrophy During
Humeral Elevation Tasks
Johannes Maria Nicolaas Essers , Anneliek Peters, Kenneth Meijer,
Koen Peters, and Alessio Murgia , Member, IEEE
Abstract— Facioscapulohumeral dystrophy (FSHD) is a1
progressive muscle-wasting disease which leads to a2
decline in upper extremity functionality.Although the scapu-3
lohumeral joint’s stability and functionality are affected,4
evidence on the synergetic control of the shoulder muscles5
in FSHD individuals is still lacking.The aim of this paper is to6
understand the neuromuscular changes in shoulder muscle7
control in people with FSHD. Upper arm kinematics and8
electromyograms (EMG) of eight upper extremity muscles9
were recorded during shoulder abduction-adduction and10
flexion-extension tasks in eleven participants with FSHD11
and 11 healthy participants. Normalized muscle activities12
were extracted from EMG signals. Non-negative matrix fac-13
torization was used to compute muscle synergies.Maximum14
muscle activities were compared using non-parametric15
analysis of variance. Similarities between synergies were16
also calculated using correlation. The Biceps Brachii was17
significantly more active in the FSHD group (25±2%) while18
Trapezius Ascendens and Serratus Anterior were less active19
(32±7% and 39±4%, respectively). Muscle synergy weights20
were altered in FSHD individuals and showed greater diver-21
sity while controls mostly used one synergy for both tasks.22
The decreased activity by selected scapula rotator muscles23
and muscle synergy weight alterations show that neuromus-24
cular control of the scapulohumeral joint is less consistent25
in people with FSHD compared to healthy participants.26
Assessments of muscle coordinationstrategies can be used27
to evaluate motor output variability and assist in manage-28
ment of the disease.29
Index Terms— FSHD, humeral elevation, motor control,30
muscular dystrophy, muscle synergies, scapula rotation.31
I. INTRODUCTION32
FACIOSCAPULOHUMERAL Dystrophy (FSHD) is char-33 acterized by progressive muscle wasting which primarily34
affects the face and shoulder area [1], [2]. Muscle quality35
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decreases due to fat infiltration, but is weakly correlated 36
with age where age onset varies greatly [2], [3]. Commonly 37
occurring body impairments and functional limitations include 38
scapular winging, joint instability, and a decline in upper 39
extremity functionality [4]–[8]. In a questionnaire-based sur- 40
vey, reaching and lifting objects above shoulder level were 41
reported as “most limited” activities by 45% of FSHD par- 42
ticipants [6]. Relative surface area, as a measure of the 43
reachable workspace, decreases by 23 to 87% depending on 44
the level of strength loss, in people with FSHD [9], [10]. 45
Muscles attaching to the scapula are the most affected, with the 46
Trapezius and Serratus Anterior muscles becoming atrophied 47
and showing fat infiltration in more than 85% of individuals 48
with FSHD [11]. These losses in tissue quantity and quality 49
become evident at the earliest stages of the disease [11], [12] 50
and translate into a diminished strength of the scapular rotator 51
muscles. In turn, this limited muscle function could result in 52
incomplete rotation and stabilization of the scapula. 53
Electromyographic assessments of muscle function can 54
provide insight in the muscle activation strategies used for 55
scapular stabilization and mobilization in people with FSHD. 56
Previous research has shown an approximately twice as high 57
muscle activity in FSHD participants compared to healthy 58
individuals for the Deltoid, Trapezius Descendens, and syner- 59
gist Biceps muscles during reaching tasks [13]. The increased 60
activity of selected shoulder muscles can be postulated to 61
compensate for the loss of strength, with scapular mobilization 62
possibly affected as a result. In healthy individuals, scapular 63
mobilization and stability are necessary during humeral eleva- 64
tion, particularly above shoulder level [14]–[16]. At present 65
however, the way in which scapular rotator and humeral 66
elevator muscles are coordinated by FSHD individuals during 67
daily tasks is still unclear. The extent of these alterations that 68
are known to occur in other diseases affecting the shoulder, 69
including stroke, multiple sclerosis, and shoulder impinge- 70
ment [17]–[22], indicate that the neuromuscular output can 71
be affected by the disease. 72
Muscle synergy analysis can be used to reveal alterations in 73
the coordination of groups of muscles. In healthy individuals 74
the central nervous system activates muscles in groups, as a 75
neural strategy to simplify the control of multiple degrees 76
of freedom [23]. These group activations, commonly called 77
1534-4320 © 2019 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
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muscle synergies, can be described by the relative contribution78
of each muscle (weights) during a common time-dependent79
activation command (coefficients) [24]. Muscle synergy analy-80
sis of the upper extremity in people post-stroke has revealed81
alterations in the shoulder muscle synergies during isometric82
force generation [25] and dynamic tasks [26]. A high similarity83
between affected and unaffected arm muscle synergies was84
shown in a variety of daily activities, together with the pres-85
ence of compensatory strategies by Trapezius and Pectoralis86
muscles during reaching tasks [25], [27], [28]. In people87
with FSHD, however, it is unknown how muscle synergies88
change during the execution of upper extremity daily tasks.89
Understanding the neuromuscular output can help reveal how90
the disease-resulting changes in kinematics are underlined91
by muscular changes, with implications for the long-term92
management of the condition.93
This study concentrates on planar humeral elevation tasks to94
understand the neuromuscular changes affecting the shoulder95
muscles, including muscles responsible for scapula rotation96
and stabilization, in people with FSHD compared to healthy97
individuals. We hypothesized that in people with FSHD the98
maximum activity of prime movers of humerus and scapula99
and of synergist muscles would be higher compared to healthy100
individuals. Secondly, we also hypothesized that muscle syn-101
ergies would show alterations in people with FSHD, reflecting102
the increase in maximum activity, mainly in synergy weights.103
The second hypothesis was tested to investigate whether the104
known shoulder mobility limitations in people with FSHD105
would affect the muscle synergies.106
II. METHODS107
A. Participants108
Eleven healthy control participants (5M/6F, 55±14ys,109
175±7cm, 69±8kg, 11Right-Dominant (RD)) and eleven par-110
ticipants with FSHD (6M/5F, 54±15ys, 177±11cm, 78±21kg,111
2LD/9RD) were included in this study. Healthy participants112
were informed by advertisement flyers located at University113
Medical Center Groningen. People with FSHD were informed114
about the study through the Dutch Association for Neuromus-115
cular Diseases (Spierziekten Nederland, Baarn, NL). Healthy116
and participants with FSHD were included in this study if they117
were aged between 18-75 years, able to read and understand118
Dutch, and able to give written informed consent. Additional119
criteria for people with FSHD were the ability to transfer120
from wheelchair to chair with side- and lower back-rest, and121
a Brooke scale score of 3 or 4. Healthy participants were122
excluded if they were diagnosed with pathologies that could123
interfere with the measurement results, had a presence of pain124
in the shoulder, a history of severe trauma of the shoulder125
within the previous two years (e.g. fracture, luxation). Partic-126
ipants with FSHD were excluded if they had comorbidities127
that could interfere with the measurement results, previous128
surgery on the right shoulder, extrinsic causes of shoulder129
pain, a history of severe trauma, or were unable to elevate130
the right arm above 30◦. Age, gender, hand-dominance, body131
height, and body mass were also recorded. The central Medical132
Ethical Committee of University Medical Center Groningen133
Fig. 1. Experimental set up of a FSHD participant about to perform
shoulder abduction-adduction (left) and flexion-extension (right).
approved the study (NL55711.042.15), which was carried out 134
in accordance with the guidelines of the Helsinki protocol. Par- 135
ticipants were informed about the procedure beforehand and 136
provided written informed consent. 137
B. Movement Tasks 138
The participants were positioned in a chair with a left 139
side-rest and lower back-rest and with the seat height adjusted 140
to achieve a knee flexion angle of 90◦. Participants received 141
detailed instructions prior to the execution of each task regard- 142
ing the movement. For the shoulder abduction-adduction task 143
(SAA), the right arm was first positioned downward with the 144
elbow straight and the hand palm facing forward (Fig. 1). The 145
movement consisted of lifting the arm as far as possible in 146
the coronal plane and bringing it back to the start position 147
while keeping the trunk and elbow straight, with the hand palm 148
facing forward. The shoulder flexion-extension task (SFE) was 149
similarly executed but with the hand palm facing medially and 150
the thumb pointing forward. One researcher mirrored each task 151
at pace with the participant. Each task was repeated three times 152
but not consecutively as the order of the tasks was randomized. 153
C. Measurement and Processing 154
Kinematics of the trunk, chest, and right-sided upper 155
extremity was recorded using the Optotrak 3020 system 156
(Northern Digital Inc., Canada) [29]. Single markers were 157
placed on bone landmarks and rigid bodies were placed on soft 158
tissues on the lateral side of the upper and lower arm as shown 159
in table 1. Humeral elevation was calculated from the recorded 160
kinematics and expressed as joint angle between trunk and 161
humerus where 0◦ represents the arm straight downward and 162
180◦ straight upward. 163
Surface electromyograms (EMG) of the right side muscles 164
were recorded for the prime humeral elevator/depressors and 165
scapular rotator muscles, i.e. medial Deltoid, Pectoralis Major 166
clavicular head, Latissimus Dorsi, Trapezius Descendens, 167
Trapezius Ascendens, and Serratus Anterior 5-6th rib, and 168
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TABLE I
SINGLE AND RIGID BODY MARKERS
the synergist muscles Biceps Brachii short head and Triceps169
Brachii long head. Data were captured at 2000Hz using the170
Delsys Trigno system (Delsys Inc., UK) [30]. Maximum171
voluntary contractions (MVCs) were recorded beforehand172
(appendix, table 2). The recorded EMG data were filtered with173
a 4th order Butterworth 20-450Hz bandpass and a 49-51Hz174
bandstop filter, rectified, smoothened with a 100ms moving175
window, normalized to the maximum amplitudes derived from176
all MVC and task recordings, and filtered with a 4th order177
Butterworth 5Hz low pass filter. The maximum task-specific178
muscle activity was extracted as highest normalized amplitude179
over all task repetitions. Time was normalized to 1001 samples180
for each repetition ranging from 0 to 100%.181
Kinematics and EMG recordings were executed consistently182
with one researcher placing the markers and electrodes and183
another research assessing the placement and data quality.184
D. Muscle Synergy Extraction185
EMG data were pooled per participant to contain equal sam-186
ples of both tasks in a single matrix to investigate the shared187
synergies across humeral elevation planes. Muscle synergies188
were then extracted using Non-Negative Matrix Factorization189
(NNMF), which decomposed the matrix into 1 to 8 sets of190
components consisting of weights and coefficients [24]. These191
weights and coefficients were converted to a unit vector and192
represent normalized muscle activity (0-1). Additionally, for193
each set of components (synergy), the NNMF provided the194
percentage of variance accounted for of all muscles (VAF)195
and per individual muscle (VAFM). The minimum required196
number of synergies per participant were extracted using as197
thresholds VAF > 90% and VAFM > 75% [24]. The variance198
accounted for per task was calculated with respect to the199
reconstructed data (weights ∗ coefficients) for each synergy.200
Coefficients were then averaged for pooled repetitions per task.201
Synergies were clustered within each group using an iterative202
process that matched weights in an ascending order based on203
Pearson’s correlation coefficients.204
The muscle synergy extraction procedure was executed for205
two conditions. One condition included the complete motion206
and the second condition focused on the upward motion up to 207
60◦ humeral elevation. 208
E. Statistical Analysis 209
Humeral elevation differences between groups were inves- 210
tigated using independent-samples Mann-Whitney U tests. 211
To test the first hypothesis on whether EMG amplitudes 212
of prime movers and synergist muscles would be higher 213
in people with FSHD, the maximum muscle activities were 214
compared using a non-parametric analysis of variance, with 215
Task and Muscle as within-group factors and Group as 216
between-group factor (R v3.5.0, The R Foundation for Statisti- 217
cal Computing, nparLD package) [31]. The Post-hoc tests were 218
performed accordingly between groups using independent- 219
samples Mann-Whitney U tests, and between tasks using 220
related-samples Wilcoxon signed rank tests. Alpha levels were 221
corrected for multiple comparisons and set at 0.025. Effect 222
sizes were expressed as Cohen’s d (very small: 0.00- 0.01, 223
small: 0.01 - 0.20, medium: 0.20 - 0.50, large: 0.50 - 0.80, 224
very large: 0.80 - 1.20, and huge: >1.20) [32]. Furthermore, 225
the standard error of measurement (SEM) was calculated on 226
the consistency of maximum muscle activity over repetitions 227
for each group and consequently used to calculate standard 228
deviations of mean group differences [33]. 229
To test the second hypothesis on whether muscle synergies 230
were altered or dissimilar in people with FSHD, Pearson’s cor- 231
relation coefficients were used to quantify synergy weight and 232
zero-lag correlation coefficients to quantify synergy coefficient 233
similarities (α: 0.025) [34]. Correlation coefficients values 234
were calculated only for significantly similar synergy weights 235
to minimize type I errors. Additionally, within-group similarity 236
was calculated through the EMG cross-validation method [35], 237
and Pearson correlations for synergy weights only. Differences 238
in within-group similarity from EMG cross-validations were 239
tested with Fisher’s least significant difference (LSD) post-hoc 240
test with the number of muscle synergies as a factor (α: 0.025). 241
III. RESULTS 242
A. Kinematics 243
All participants successfully completed all tasks. The con- 244
trol group elevated the humerus significantly higher in SAA 245
to 149 ± 19◦ (N = 22, Cohens d : 4.28, p < 0.001) and in 246
SFE to 141±17◦(N = 22, Cohens d : 3.09, p < 0.001). The 247
FSHD group’s maximum humeral elevation was 70 ± 18◦ and 248
83 ± 20◦ during the SAA and SFE task, respectively. 249
B. Muscle Activity 250
Maximum muscle activities were significantly different for 251
Task (p < 0.010), Muscle (p < 0.001), Muscle∗Task (p < 252
0.001), Group∗Muscle (p < 0.001), and Group∗Muscle∗Task 253
(p < 0.001), but not for Group (p:0.248) or Group∗Task (p: 254
0.121). Post-hoc tests of the Group∗Muscle∗Task interaction 255
effect revealed that maximum muscle activities were signif- 256
icantly different between groups (FSHD-control) for Biceps 257
Brachii SFE: +25±2% (N = 22, Cohens d : 1.38 p : 0.013), 258
Trapezius Ascendens SAA: -32±8% (N = 22, Cohens d : 259
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Fig. 2. Boxplots of maximum muscle activity amplitudes of control (black) and FSHD group (grey) for the SAA (left) and SFE (right) tasks (∗: significant
group differences; #: task differences; p<0.025). Boxes and whiskers indicate minimum, first quartile, median, third quartile, and maximum. BB:
Biceps Brachii; DM: medial Deltoid; TB: Triceps Brachii; TD: Trapezius Descendens; TA: Trapezius Ascendens; PM: Pectoralis Major; SA: Serratus
Anterior; LD: Latissimus Dorsi.
Fig. 3. Variance accounted for as means and standard deviation (lines;
left y-axis) and number of extracted synergies (bars; right y-axis) of the
control (black) and FSHD group (grey). The dashed line indicates the
90% VAF threshold.
−1.45, p : 0.004) and SFE: -41±6% (N = 22, Cohens d :260
−1.95, p : 0.001), and Serratus Anterior SAA: -39±4%261
(N = 22, Cohens d : −1.72, p : 0.002) (Fig. 2).262
Within the control group there was a significant difference263
between tasks (SAA-SFE) for Trapezius Ascendens: -14±14%264
(N = 22, Cohens d : −0.74, p : 0.005) and Latissimus265
Dorsi: -5±6% (N = 22, Cohens d : −0.25, p : 0.024).266
Within the FSHD group significant differences between267
tasks (SAA-SFE) were found for Biceps Brachii: -12±15%268
(N = 22, Cohens d : −0.55, p : 0.010), Trapezius269
Descendens: +21±25% (N = 22, Cohens d : 0.79, p : 270
0.024), Pectoralis Major: -13±16% (N = 22, Cohens d : 271
−0.80, p : 0.010), Serratus Anterior: -19±23% (N = 272
22, Cohens d : −0.83, p : 0.014), and Latissimus Dorsi: 273
-17±18% (N = 22, Cohens d : −0.90, p : 0.019). The 274
SEMs were 1.9% and 3.3% for the control and FSHD group, 275
respectively. 276
C. Muscle Synergies 277
The number of synergies extracted were equally distributed 278
between the two groups (Fig. 3). In each group at least 279
90% of the variance was described with one synergy for two 280
participants, two synergies for eight participants, and three 281
synergies for one participant. The control and FSHD group’s 282
synergies were clustered into two sets each (Fig. 4, 5). FSHD 283
participants were also investigated individually and compared 284
to the clustered control synergies (Fig. 4, 5). Appendix Fig. 8 285
shows the participant-specific synergies. 286
Synergy #1 on average accounted for 74 ± 19% variance for 287
FSHD participants (controls: 87 ± 9%) in the SAA task and 288
50 ± 35% VAF (controls: 86 ± 9%) in the SFE task. The VAF 289
per task by synergy #2 was 29 ± 12% for FSHD participants 290
(controls: 15 ± 3%) in the SAA task and 59 ± 27% (controls: 291
15 ± 6%) in the SFE task. Within-group similarities for 292
synergy weights #1 and #2 were, respectively, for controls 293
R:0.73 ± 0.15 (N = 55) and R: -0.06 ± 0.37 (N = 36), 294
and for FSHD R:0.00 ± 0.42 (N = 55) and 0.08 ± 0.56 295
(N = 36). Correlation of synergy weights was not significant 296
for any synergy combination between groups. On an individual 297
level two FSHD participants (#6, #9) showed significant 298
similar synergy weights where synergy #1 correlated with 299
control synergy #2 (p : 0.023, R : 0.78 andp : 0.001, R : 300
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Fig. 6. Muscle synergies no. 1 (left), no. 2 (middle), and no. 3 (right) of control group (black) and FSHD group (grey) for the SAA and SFE tasks cut
up to 60◦ of humeral elevation. N equals the amount of participants within each clustered synergy. Clustered synergies are presented as a mean
(black line) with standard deviation (bars) or ±95% confidence interval (grey area). BB: Biceps Brachii; DM: medial Deltoid; TB: Triceps Brachii; TD:
Trapezius Descendens; TA: Trapezius Ascendens; PM: Pectoralis Major; SA: Serratus Anterior; LD: Latissimus Dorsi.
Fig. 7. Variance accounted for as means and standard deviation
from EMG cross-validation performed within the control (left) and FSHD
group (right) for whole motion (top) and cut to 60◦ (bottom). Bars
show calculations using participants’ own synergies (OWN), and from
others (OTH) for a complete synergy set (S#1-3) and for individual
synergies (S#1, S#2, S#3). Dashed line indicates the 90% VAF threshold.
Significant differences were indicated by ∗.
−0.92 f or partici pant#6 and#9, respectively). Correlation301
coefficients values for the SAA and SFE tasks were respec-302
tively R:0.19 and 0.24 (FSH D#6, p < 0.001 and < 0.001),303
and R:0.09 and 0.18 (FSH D#9, p : 0.006 and < 0.001).304
In the upward motion to 60◦ humeral elevation condition, at305
least 90% of the variance was described by two synergies for306
seven controls and seven FSHD participants, and three syner-307
gies for four controls and one FSHD participant. Three FSHD308
participants did not reach at least 60◦ in both tasks and were309
excluded for this condition. Control and FSHD participants’310
synergies were clustered into three sets each (Fig. 6). Synergy311
#1 accounted for 63±11% variance for FSHD participants312
(controls: 62±17%) in the SAA task and 39±10% (controls:313
45±16%) in the SFE task. For synergy #2 this was 37±10%314
and 56±16% (controls: 29±21%, 47±16%) in the SAA and315
SFE tasks respectively, and 6% and 41% (controls: 24±9%, 316
21±19%) for synergy #3. Synergy weights showed significant 317
similarities between groups for synergy #1 (R:0.84, p:0.009) 318
where correlation coefficients values showed R:0.98 ( p < 319
0.001) for both tasks. 320
EMG cross-validations showed that less variance was 321
accounted for by other participants’ complete synergy set than 322
one’s own set in the control ( p < 0.001) and FSHD group 323
(p < 0.001, fig. 7). With the exception of controls’ synergy 324
#1, other participants’ individual synergies accounted for less 325
variance than the complete set ( p < 0.001). Upon further 326
inspection, synergy #2 accounted for an additional 5±2% VAF 327
in controls after which the criteria of >90% was met for 328
8 participants (Fig. 3). In the upward to 60◦ humeral elevation 329
condition all factors accounted for less variance than one’s own 330
synergy set ( p < 0.025). 331
IV. DISCUSSION 332
The activities of eight superficial shoulder muscles were 333
studied to investigate the changes in neuromuscular output in 334
people with FSHD during humeral elevation. We hypothesized 335
that the maximum activities of humeral elevator, scapular 336
rotator and synergist muscles would be increased. This was 337
confirmed for the Biceps Brachii (SFE task only). Contrary 338
to what was expected the activity of the scapular rotators 339
Trapezius Ascendens and Serratus Anterior (SAA task only) 340
significantly decreased in people with FSHD. Additionally, 341
it was hypothesized that the muscle synergies would be altered 342
as a result of the impaired muscle functionality. Along this 343
line, the synergies between groups were found to differ in 344
importance for the complete motion: within group similarity 345
indicated that controls mostly used one synergy for both tasks 346
while the majority of the FSHD group required two task- 347
specific synergies. From the comparable kinematic data and 348
maximum muscle activities it can be concluded that while 349
synergy weights were similar up to 60◦ humeral elevation, 350
the Trapezius Ascendens and Serratus Anterior contributed on 351
average less to humeral elevation in the FSHD than in the 352
control group. The irregularity of variances accounted for per 353
task by each synergy and the difference in maximum muscle 354
activities, and synergy weights and coefficients, suggest the 355
presence of participant-specific adaptation mechanisms. 356
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The muscle activities of the control group for medial Deltoid357
(40-69%), Serratus Anterior (60-65%), Trapezius Ascendens358
(45-60%), Trapezius Descendens (35-55%), Latissimus Dorsi359
(10-23%), and Pectoralis Major (5-20%) during shoulder360
abduction-adduction or flexion-extension were consistent with361
other literature findings [13]–[15]. Maximum elevation angles362
in the control and FSHD group were also in line with a compa-363
rable study [13], while trends in increased activity of Trapezius364
Descendens and Pectoralis Major found by others [13] were365
not significant in this study. This could be ascribed to the large366
variability in muscle activation of people with FSHD [36], and367
partly to methodological differences in the MVCs protocol368
used for the Trapezius Descendens. In this study a strap over369
the shoulder was used to limit the participants’ movements370
during the Trapezius Descendens MVCs recordings, while371
in [13] the participants’ shoulders were manually restrained.372
The activities of the lower scapular rotator muscles during373
humeral elevation tasks in FSHD are presented for the first374
time in this study. The decreased activities of Trapezius375
Ascendens and Serratus Anterior muscles reveal that these376
scapular lateral rotators generated a lower force and thus a377
lower moment to rotate the scapula, a movement which is378
necessary during humeral elevation [16]. This insufficiency379
was confirmed by visual observations of very limited scapular380
rotation in the FSHD group. The decreased activity of these381
muscles appears to be a characteristic signature of the FSHD382
disease, which is in contrast with an increased activity of383
Trapezius Ascendens and Serratus Anterior found in shoulder384
impingement and post-stroke patients [17]–[22]. Ultimately,385
the inability to laterally rotate the scapula leads to a decrease386
in humeral elevation. This situation could produce unnecessary387
stress on the rotator cuff muscles, which provide a stabilizing388
function of the glenohumeral head and are preserved in FSHD389
individuals, based on MRI evidence [11], [12]. The increased390
synergist Biceps Brachii activity likely assisted in the stabi-391
lization of the humeral head and the elevation of the humerus392
within the decreased range of scapular motion [37]. However,393
a larger variability in muscle contributions did not reveal394
a clear relationship between the activity of lower scapular395
rotators or synergist muscles and the amount of humeral396
elevation.397
At the level of intra-task differences between SAA and398
SFE, a significant increased activity in the FSHD group was399
found for the Serratus Anterior and Pectoralis Major while400
an increased activity trend occurred for the Trapezius Ascen-401
dens muscle. The higher activity of the Pectoralis Major is402
consistent with the greater abduction moment required during403
forward flexion. Furthermore, more scapulothoracic internal404
rotation is known to occur in healthy shoulders during shoulder405
flexion-extension than abduction-adduction [16], while exter-406
nal rotation of the scapula increases following Serratus Ante-407
rior fatigue [38]. A higher activity of the Trapezius Ascendens408
and Serratus Anterior during shoulder flexion-extension is409
therefore consistent with the requirements for more internal410
scapula rotation and joint stability.411
In order to understand whether the coordinated activity,412
i.e. synergy weights, of selected muscles underlines possible413
compensatory strategies in the FSHD group, a muscle synergy414
analysis was carried out and presented here for the first 415
time in this population. The synergies accounting for the 416
highest proportion of the VAF (Fig. 4, 5) showed a changed 417
coordinating action of humeral elevator and scapular rotator 418
muscles. Specifically, synergy #1 for the control group was 419
most likely responsible for glenohumeral elevation, scapula 420
rotation and scapula stabilization, as exemplified by the main 421
contributions of the Deltoid Medial, Trapezius Descendens and 422
Ascendens, Serratus Anterior, and Latissimus Dorsi muscles. 423
Synergy #1 for the FSHD group showed involvement of the 424
Deltoid Medial and Trapezius Descendens and was therefore 425
most likely responsible for glenohumeral elevation and scapula 426
upward rotation. Contributions from the Trapezius Ascendens, 427
Serratus Anterior, and Latissimus Dorsi muscles appeared 428
diminished compared to the control group, reflecting the differ- 429
ences found in maximum muscle activity. The controls’ second 430
synergy was characterized by low muscle activation and fol- 431
lows from the methodological choice of accounting for >90% 432
variance of all muscles. We postulate that this second synergy 433
is a collection of short activation bursts (<20%) from different 434
muscles, possibly to stabilize or facilitate the movement. Eight 435
out of eleven FSHD participants used a second synergy with 436
distinct coefficients for the SFE task. This second synergy was 437
most likely responsible for scapula rotation and stabilization. 438
This synergy also differs from the first in the contributions 439
from Trapezius Ascendens and Serratus Anterior, reflecting 440
the task-specific differences found in maximum muscle activ- 441
ity. Additionally, FSHD participants who applied this second 442
synergy had higher humeral elevation angles. Similarly to what 443
was found for the maximum activity, no clear relationships 444
was present between the humeral elevation angles achieved 445
and the amount of required synergies and/or involvement 446
of scapula rotator/stabilizer muscles. The variety in muscle 447
synergies compositions shows evidence that muscle control is 448
less consistent in FSHD. 449
The synergy coefficients of similar synergy weights cor- 450
related poorly between groups. However, considering that 451
the similarities were computed between two synergies of a 452
high VAF proportion (FSHD) vs. a clustered synergy of a 453
low VAF proportion (control), it is questionable whether the 454
comparison is representative of the change at a group level. 455
Additionally, EMG cross-validations indicated a larger data 456
similarity within the controls than the FSHD group, revealing 457
a higher consistency in muscle activation in the former group. 458
Future analysis should specifically focus on evaluation of 459
within-group similarity of synergy weights and coefficients. 460
In summary, coordination differences in FSHD appear to 461
reflect the physiological changes of muscles due to the disease. 462
On the basis of the above findings it is evident that FSHD 463
can lead to alterations in the coordination of muscle groups and 464
lead to altered function and thus performance in some individ- 465
uals. Muscle strengthening therapy, including scapular control, 466
is sometimes considered part of the rehabilitation treatment 467
for impingement and scapular winging [42]–[44]. Although 468
scapular control therapy remains a debated topic [45], future 469
research should explore whether this therapy could be effective 470
in people with FSHD [36], [46]. Given the limited function 471
of the scapular rotators it is likely that therapeutic decisions 472
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should be made on an individual level, after careful assessment473
of the muscles’ coordination using a methodology similar to474
the one proposed in this study.475
A. Limitations476
Muscle synergy analysis was shown to be sensitive to detect477
changes in motor output with respect to internal/external fac-478
tors, however the technique has its limitations. The outcomes479
can be influenced by the choices made in EMG processing,480
NNMF settings, and threshold of VAFs [39], [40], [47], [48].481
For example, a lower VAF threshold would reduce the required482
number of synergies, possibly oversimplifying the motor out-483
put. To overcome this problem, this study uses two thresholds484
to ensure the variance of all muscles have been accounted for485
on a collective as well as a singular level [24]. In addition,486
the statistical approach was thorough and ensured that the487
limitations did not affect the conclusions.488
The number of muscle synergies were inconsistent between489
participants and resulted in two clustered synergies of eleven490
and nine participants. However, this can be explained by indi-491
vidual characteristics, unrelated to disease effects [39], [40].492
Furthermore, the total number of synergies were equal between493
the groups. Nonetheless, this could have resulted in the494
large within-group variances, specifically in muscle synergy495
weights, where a common coordinating activity is only evident496
for selected muscles [41]. The presented clustering method497
is suitable for simple movements as examined in this study,498
but arguably not when multiple synergies are needed, for499
example during more complex motions. Other cluster analysis500
methods can be used to pool synergies based on more distinct501
weights [27], [28] and are recommended in future research.502
V. CONCLUSION503
People with FSHD showed motor output alterations dur-504
ing humeral elevation, which were often movement- and505
participant-dependent. In general, the lower scapula rotators506
showed decreases in activity, with compensatory increase507
of a synergistic upper arm muscle. A group∗muscle∗task508
interaction effect was accompanied with increased activities509
of the lower scapula rotators, and synergistic chest and510
upper arm muscles during shoulder flexion-extension com-511
pared with abduction-adduction. The large group variances512
indicate that individual characteristics have a large influence513
on motor output. An assessment of the muscles’ coordination514
is recommended to reveal individual synergies and to design515
evidence-based therapy for the management of the condition.516
APPENDIX517
See Fig. 8 and Table II.518
ACKNOWLEDGMENT519
Authors would like to thank the Netherlands Organisation520
for Scientific Research (Den Haag, NL) for funding the Sym-521
bionics Perspectief Program project 13523 ADAPT, and the522
Dutch Association for Neuromuscular Diseases (Spierziekten523
Nederland, Baarn, NL) for their collaboration in the inclusion524
process by informing their members of this study.525
Fig. 8. Participant-specific muscle synergy of a control participant
(black, 9% VAF) and FSHD participant #6 (dark cyan, 19% VAF) for
the SAA and SFE tasks. N equals the amount of participants within
the clustered synergy. Individual synergy coefficients show upward
(black line) and downward motion (grey line). Participant #6 has three
synergies. BB: Biceps Brachii; DM: medial Deltoid; TB: Triceps Brachii;
TD: Trapezius Descendens; TA: Trapezius Ascendens; PM: Pectoralis
Major; SA: Serratus Anterior; LD: Latissimus Dorsi.
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